Physician

Cheryl Reis Robertson, M.D.

According to 2025 Medicare claims, Cheryl Robertson, M.D. (NPI: 1851312243) practices rheumatology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is ARTHRITIS AND OSTEOPOROSIS CONSULTANTS OF THE CAROLINAS PA (NPI: 1801843925; TIN: 562202409) and primary practice location at 28277-3416.

Robertson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 590 traditional Medicare patients, billed 111,335 HCPCS/CPT codes, and received $1,716,368 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 3,110 prescription claims across 483 beneficiaries totaling $2,342,762 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 45 records totaling $986. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $998,697 and ending at $1,716,368. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $697,126 to $2,342,762. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	823	41,187	$998,697
2016	858	54,637	$1,488,745
2017	870	72,821	$1,856,317
2018	522	52,687	$1,483,646
2019	586	74,992	$1,714,541
2020	735	109,395	$2,293,560
2021	673	91,304	$1,786,321
2022	637	92,282	$1,638,681
2023	561	99,455	$1,468,580
2024	590	111,335	$1,716,368

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	428	3,172	$697,126
2016	460	3,307	$926,360
2017	513	3,625	$1,268,008
2018	528	3,322	$1,334,841
2019	496	3,324	$1,455,114
2020	501	3,800	$1,684,871
2021	516	3,541	$1,634,027
2022	530	3,634	$1,912,182
2023	488	3,130	$1,810,951
2024	483	3,110	$2,342,762

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	188	528	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	337	608	$95
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	99	279	$56
77089	Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk	108	108	$30
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	324	493	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	91	2,562	$704,550
Enbrel	Etanercept	53	1,736	$449,543
Humira(Cf) Pen	Adalimumab	38	1,232	$434,250
Rinvoq	Upadacitinib	20	780	$173,542
Humira(Cf)	Adalimumab	11	308	$156,036

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$986	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cheryl Reis Robertson, M.D.?

Tedicare shows public-source Medicare data for Cheryl Reis Robertson, M.D. (NPI 1851312243), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cheryl Reis Robertson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Cheryl Reis Robertson, M.D.?

Cheryl Reis Robertson, M.D. is linked to ARTHRITIS AND OSTEOPOROSIS CONSULTANTS OF THE CAROLINAS PA (billing NPI 1801843925) in the available physician profile data.

Does Cheryl Reis Robertson, M.D. have Open Payments data?

Cheryl Reis Robertson, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.